- Home
- JHI vs IRWD Comparison
JHI vs IRWD Comparison
Compare JHI & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JHI
- IRWD
- Stock Information
- Founded
- JHI 1971
- IRWD 1998
- Country
- JHI United States
- IRWD United States
- Employees
- JHI N/A
- IRWD N/A
- Industry
- JHI Trusts Except Educational Religious and Charitable
- IRWD Biotechnology: Pharmaceutical Preparations
- Sector
- JHI Finance
- IRWD Health Care
- Exchange
- JHI Nasdaq
- IRWD Nasdaq
- Market Cap
- JHI 120.3M
- IRWD 124.0M
- IPO Year
- JHI N/A
- IRWD 2010
- Fundamental
- Price
- JHI $13.86
- IRWD $0.75
- Analyst Decision
- JHI
- IRWD Buy
- Analyst Count
- JHI 0
- IRWD 5
- Target Price
- JHI N/A
- IRWD $4.94
- AVG Volume (30 Days)
- JHI 29.5K
- IRWD 1.8M
- Earning Date
- JHI 01-01-0001
- IRWD 08-07-2025
- Dividend Yield
- JHI 6.80%
- IRWD N/A
- EPS Growth
- JHI N/A
- IRWD N/A
- EPS
- JHI 1.05
- IRWD N/A
- Revenue
- JHI N/A
- IRWD $317,676,000.00
- Revenue This Year
- JHI N/A
- IRWD N/A
- Revenue Next Year
- JHI N/A
- IRWD N/A
- P/E Ratio
- JHI $12.47
- IRWD N/A
- Revenue Growth
- JHI N/A
- IRWD N/A
- 52 Week Low
- JHI $11.63
- IRWD $0.53
- 52 Week High
- JHI $13.40
- IRWD $7.11
- Technical
- Relative Strength Index (RSI)
- JHI 63.47
- IRWD 54.95
- Support Level
- JHI $13.77
- IRWD $0.70
- Resistance Level
- JHI $14.00
- IRWD $0.77
- Average True Range (ATR)
- JHI 0.11
- IRWD 0.06
- MACD
- JHI 0.01
- IRWD 0.01
- Stochastic Oscillator
- JHI 74.55
- IRWD 72.44
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.